Keyword: AirDuo RespiClick
Amid a continued fight over drug prices, eight top pharmas and leading PBM Express Scripts have teamed up to offer cheaper meds to patients forced to pay cash for their meds.
Being among the world’s largest generic drug players certainly comes with its challenges. With 57,000 full-time employees around the globe, Israel’s Teva Pharmaceutical Industries came in at No. 3 among the world’s top generic drugmakers, raking in $8.8 billion with its copycats last year.
With anticipated generics, Express Scripts is looking to save on GlaxoSmithKline’s big-selling Advair.
Teva is launching AirDuo RespiClick and an authorized generic, the latter at a significant discount to GSK's Advair.
Thanks to some crafty payer negotiating from GSK, even if Advair generics win approval, it may be a while before they gain serious traction, even if it wins approval on time.
Teva has its green light for a new challenger to GSK’s respiratory giant Advair. No, it’s not the long-awaited substitutable generic—but it may still amp up pressure in the field.